(Q37701744)

22 August 2017

1 reference

title

Bitter melon: antagonist to cancer (English)

1 reference

22 August 2017

2

Ratna B Ray

1 reference

22 August 2017

Pratibha Nerurkar

1

1 reference

22 August 2017

publication date

3 March 2010

1 reference

22 August 2017

published in

Pharmaceutical Research

1 reference

22 August 2017

volume

27

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

1049-1053

1 reference

Momordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phosphoinositide-3 kinase interactions

22 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11095-010-0057-2

Dietary conjugated linolenic acid inhibits azoxymethane-induced colonic aberrant crypt foci in rats

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11095-010-0057-2

Tumor growth suppression by alpha-eleostearic acid, a linolenic acid isomer with a conjugated triene system, via lipid peroxidation

21 January 2018

1 reference

12 December 2020

Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis

1 reference

12 December 2020

Alpha-eleostearic acid and its dihydroxy derivative are major apoptosis-inducing components of bitter gourd

1 reference

12 December 2020

Structures of new cucurbitane-type triterpenes and glycosides, karavilagenins and karavilosides, from the dried fruit of Momordica charantia L. in Sri Lanka

1 reference

12 December 2020

Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat

1 reference

12 December 2020

Inhibition of MDA-MB-231 human breast tumor xenografts and HER2 expression by anti-tumor agents GAP31 and MAP30

1 reference

12 December 2020

The Hallmarks of Cancer

1 reference

12 December 2020

Cancer chemoprevention with dietary phytochemicals

1 reference

12 December 2020

Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells

1 reference

12 December 2020

Anti-tumor activity and immunological modification of ribosome-inactivating protein (RIP) from Momordica charantia by covalent attachment of polyethylene glycol

1 reference

12 December 2020

Effects of bitter melon (Momordica charantia l.) or ginger rhizome (Zingiber offifinale rosc) on spontaneous mammary tumorigenesis in SHN mice

1 reference

12 December 2020

Eleostearic Acid inhibits breast cancer proliferation by means of an oxidation-dependent mechanism

1 reference

12 December 2020

Pharmacological actions and potential uses of Momordica charantia: a review

1 reference

12 December 2020

American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer With Healthy Food Choices and Physical Activity

1 reference

12 December 2020

Cucurbitane-type triterpenoids from the fruits of Momordica charantia and their cancer chemopreventive effects

1 reference

12 December 2020

Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways

1 reference

12 December 2020

In vivo antitumor activity of the bitter melon (Momordica charantia)

1 reference

12 December 2020

Anticancer and cancer chemopreventive potential of grape seed extract and other grape-based products

1 reference

12 December 2020

Lipid lowering effects of Momordica charantia (Bitter Melon) in HIV-1-protease inhibitor-treated human hepatoma cells, HepG2.

1 reference

12 December 2020

10.1007/S11095-010-0057-2

Identifiers

DOI

1 reference

22 August 2017

1 reference